Philip Kantoff

Dr. Kantoff serves as a Scientific and Clinical Advisor to PrognomiQ. He is the Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), where he oversees a department of almost 500 physicians. Before joining MSK, he was the Jerome and Nancy Kohlberg Chair at Harvard Medical School and served as the Director of the Lank Center for Genitourinary Oncology, Chief of the Division of Solid Tumor Oncology, Vice Chair of the Department of Medical Oncology, and Chair of the Executive Committee on Clinical Research at the Dana-Farber Cancer Institute. Dr. Kantoff’s research focuses on developing improved treatments for patients with genitourinary cancers, including understanding the molecular basis of prostate cancer. He served as Chairman of Prostate Cancer Foundation’s Global Research Council. Dr. Kantoff received his undergraduate and medical degrees from Brown University.